These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7634895)

  • 1. The effect of dietary sodium on the concentrations of vasoactive intestinal peptide in plasma and lung.
    Ye VZ; Duggan KA
    Chest; 1995 Aug; 108(2):535-8. PubMed ID: 7634895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sodium depletion on tissue concentrations of the natriuretic hormone vasoactive intestinal peptide.
    Duggan KA; Ye VZ
    Clin Exp Pharmacol Physiol; 1995 Aug; 22(8):583-4. PubMed ID: 7586717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of enalapril on vasoactive intestinal peptide metabolism and tissue levels.
    Duggan KA; Ye VZ
    Eur J Pharmacol; 1998 Sep; 358(1):25-30. PubMed ID: 9809865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat.
    Ye VZ; Hodge G; Yong JL; Duggan KA
    Acta Physiol Scand; 2003 Dec; 179(4):353-60. PubMed ID: 14656372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increases in the myocardial concentration of vasoactive intestinal peptide may explain the positive inotropic effect of angiotensin converting enzyme inhibitors.
    Ye VZ; Duggan KA
    Clin Exp Pharmacol Physiol; 1996; 23(6-7):617-8. PubMed ID: 8800603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium depletion decreases hepatic metabolism of vasoactive intestinal peptide in the rabbit.
    Duggan KA; Hawley CM; Macdonald GJ; Shelley S
    J Physiol; 1989 Nov; 418():251-9. PubMed ID: 2621618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibition with enalapril increases the cardiac concentration of vasoactive intestinal peptide.
    Duggan KA; Ye VZ
    Ann N Y Acad Sci; 1996 Dec; 805():713-6. PubMed ID: 8993466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of a high sodium diet on the metabolism and secretion of vasoactive intestinal peptide in the rabbit.
    Davis RE; Shelley S; MacDonald GJ; Duggan KA
    J Physiol; 1992; 451():17-23. PubMed ID: 1403810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sodium depletion by frusemide on tissue concentrations and metabolism of VIP.
    Duggan KA; Ye VZ
    Ann N Y Acad Sci; 1998 Dec; 865():515-8. PubMed ID: 9928060
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of neutral endopeptidase on plasma and tissue concentrations of vaso-active intestinal peptide.
    Duggan KA; Jones DM; Davis RE; Macdonald GJ
    Clin Exp Pharmacol Physiol; 1994 Apr; 21(4):307-9. PubMed ID: 7923896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early myocardial fibrosis is associated with depletion of vasoactive intestinal peptide in rat heart.
    Ye VZ; Hodge G; Yong JL; Duggan KA
    Exp Physiol; 2002 Sep; 87(5):539-46. PubMed ID: 12481928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asbestos-related increase in pulmonary levels of vasoactive intestinal peptide (VIP).
    Day R; Lemaire I; Mercier P; Beaudoin H; Lemaire S
    Life Sci; 1983 Nov; 33(19):1869-76. PubMed ID: 6196589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of endopeptidase 24.11 inhibition on plasma and tissue concentrations of vasoactive intestinal peptide.
    Duggan KA; Jones DM; Ye VZ; Davis RE; Macdonald GJ
    Clin Sci (Lond); 1995 Sep; 89(3):267-71. PubMed ID: 7493422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide in cirrhotic rats: hemodynamic effects and mesenteric arterial receptor characteristics.
    Lee SS; Huang M; Ma Z; Rorstad O
    Hepatology; 1996 May; 23(5):1174-80. PubMed ID: 8621151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal peptide regulates angiotensin II catabolism in the rabbit.
    Davis RE; Ye VZ; Macdonald GJ; Duggan KA
    Acta Physiol Scand; 1995 Mar; 153(3):255-61. PubMed ID: 7625178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of vasoactive intestinal peptide release and metabolism by sodium.
    Duggan KA; Shelley S; Macdonald GJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S21-3. PubMed ID: 1708016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide infusion reverses existing myocardial fibrosis in the rat.
    Duggan KA; Hodge G; Chen J; Hunter T
    Eur J Pharmacol; 2019 Nov; 862():172629. PubMed ID: 31449808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of vasoactive intestinal peptide by isolated, ventilated, and perfused rat lungs.
    Bernhard W; Bothe-Sandtfort E; Koop H; Cassel W; Von Wichert P
    Eur J Clin Invest; 1989 Dec; 19(6):506-13. PubMed ID: 2515970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung.
    Ciabattoni G; Montuschi P; Currò D; Togna G; Preziosi P
    Br J Pharmacol; 1993 May; 109(1):243-50. PubMed ID: 8495242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide down-regulates the intrahepatic renin-angiotensin system in the anaesthetized rat.
    Ye VZ; Duggan KA
    Clin Sci (Lond); 2000 Sep; 99(3):201-6. PubMed ID: 11787472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.